Activation of p53 by oncogenes

Endocrine-Related Cancer

Volumn 6, Issue 1, 1999, Pages 45-48

  Lowe, S W ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RAS PROTEIN;

APOPTOSIS; CARCINOGENESIS; CELL HYPOXIA; CELL TRANSFORMATION; DNA DAMAGE; HUMAN; ONCOGENE; PROTEIN ANALYSIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ADENOVIRUS E1A PROTEINS; ANIMALS; APOPTOSIS; CELL AGING; CELL CYCLE; GENES, P53; GENES, RAS; GENES, TUMOR SUPPRESSOR; HUMANS; ONCOGENES; PROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032892932     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0060045     Document Type: Review

References (48)

1. ARF links the tumour suppressors RB and p53 [letter]. Nature 395 124-125.
2. Debbas M & White E 1993 Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes and Development 7 546-554.
3. DeGregori J, Leone G, Miron A, Jakoi L & Nevins JR 1997 Distinct roles for E2F proteins in cell growth control and apoptosis. Proceedings of the National Academy of Sciences of the USA 94 7245-7250.
4. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M & Davis RJ 1994 JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76 1025-1037.
5. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JA & Bradley A 1992 Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 215-220.
6. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters C, Penn LZ & Hancock DC 1992 Induction of apoptosis in fibroblasts by c-myc protein. Cell 69 119-128.
7. Finco TS & Baldwin AS Jr 1993 Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1. Journal of Biological Chemistry 268 17676-17679.
8. Franke TF, Kaplan DR, Cantley LC & Toker A 1997 Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275 665-668.
9. Giaccia AJ & Kastan MB 1998 The complexity of p53 modulation: emerging patterns from divergent signals. Genes and Development 12 2973-2983:
10. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ & Giaccia AJ 1994 Hypoxia induces accumulation of p53 protein, but activation of a g(1)-phase checkpoint by low-oxygen conditions is independent of p53 status. Molecular and Cellular Biology 14 6264-6277.
11. Griffiths SD, Clarke AR, Healy LE, Ross G, Ford AM, Hooper ML, Wyllie AH & Greaves M 1997 Absence of p53 permits propagation of mutant cells following genotoxic damage. Oncogene 14 523-531.
12. Haber DA 1997 Splicing into senescence: the curious case of p16 and p19ARF. Cell 91 555-558.
13. Haupt Y, Maya R, Kazaz A & Oren M 1997 Mdm2 promotes the rapid degradation of p53. Nature 387 296-299.
14. Hermeking H & Eick D 1994 Mediation of c-myc induced apoptosis by p53. Science 265 2091-2093.
15. ARF. Cell 91 649-659.
16. Kamijo T, Weber JS, Zambetti G, Zindy F, Roussel MF & Sherr CJ 1998 Interactions of the ARF tumor suppressor with p53 and Mdm2. Proceedings of the National Academy of Sciences of the USA 95 8292-8297.
17. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B & Craig RW 1991 Participation of p53 protein in the cellular response to DNA damage. Cancer Research 51 6304-6311.
18. Kubbutat MH, Jones SN & Vousden KH 1997 Regulation of p53 stability by Mdm2. Nature 387 299-303.
19. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M & Lowe SW 1998 Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes and Development 12 3008-3019.
20. Linke SP, Clarkin KC, Di Leonardo A, Tsou A & Wahl GM 1996 A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes and Development 10 934-947.
21. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T & Tlsty TD 1992 Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70 923-935.
22. Lowe SW & Ruley HE 1993 Stabilization of the p53 tumor suppressor is induced by adenovirus E1A and accompanies apoptosis. Genes and Development 7 535-545.
23. Lowe SW, Ruley HE, Jacks T & Housman DE 1993 p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74 954-967.
24. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher D, Housman DE & Jacks T 1994a p53 status and the efficacy of cancer therapy in vivo. Science 266 807-810.
25. Lowe SW, Jacks T, Housman DE & Ruley HE 1994b Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proceedings of the National Academy of Sciences of the USA 91 2026-2030.
26. ARF links the tumour suppressor p53 to Ras [letter]. Nature 395 125-126.
27. ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92 713-723.
28. Prives C 1998 Signaling to p53: breaking the MDM2-p53 circuit Cell 95 5-8.
29. Quelle DE, Zindy F, Ashmun RA & Sherr CJ 1995 Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest Cell 83 993-1000.
30. Querido E, Teodoro JG & Branton PE 1997 Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis. Journal of Virology 71 3526-3533.
31. Ridley AJ, Paterson HF, Johnston CL, Diekmann D & Hall A 1992 The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70 401-410.
32. Robinson MJ & Cobb MH 1997 Mitogen-activated protein kinase pathways. Current Opinions in Cell Biology 9 180-186.
33. Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A & Downward J 1997 Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89 457-467.
34. Samuelson AV & Lowe SW 1997 Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proceedings of the National Academy of Sciences of the USA 94 12094-12099.
35. Serrano M, Hannon GJ & Beach D 1993 A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366 704-707.
36. INK4a. Cell 88 593-602.
37. Shieh SY, Ikeda M, Taya Y & Prives C 1997 DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91 325-334.
38. Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E & Kastan MB 1997 DNA damage induces phosphorylation of the amino terminus of p53. Genes and Development 11 3471-3481.
39. ARF tumor suppressor. Genes and Development 12 2434-2442.
40. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO Journal 17 5001-5014.
41. Symonds H, Krall L, Remington L, Saenzrobles M, Lowe S, Jacks T & Van Dyke T 1994 p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78 703-711.
42. Van Aelst L, Barr M, Marcus S, Polverino A & Wigler M 1993 Complex formation between RAS and RAF and other protein kinases. Proceedings of the National Academy of Sciences of the USA 90 6213-6211.
43. Whyte P, Ruley HE & Harlow E 1988 Two regions of the adenovirus early region IA proteins are required for transformation. Journal of Virology 62 257-265.
44. Whyte P, Williamson NM & Harlow E 1989 Cellular targets for transformation by the adenovirus E1A proteins. Cell 56 67-75.
45. Yin Y, Tainsky MA, Bischoff FZ, Strong LC & Wahl GM 1992 Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles Cell 70 937-948.
46. Zhang Y, Xiong Y & Yarbrough WG 1998 ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92 725-734.
47. Zhu J, Woods D, McMahon M & Bishop JM 1998 Senescence of human fibroblasts induced by oncogenic Raf. Genes and Development 12 2997-3007.
48. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ & Roussel MF 1998 Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes and Development 12 2424-2433.